Early treatment response evaluation using FET PET compared to MRI in glioblastoma patients at first progression treated with bevacizumab plus lomustine
Norbert Galldiks*, Veronika Dunkl, Garry Ceccon, Caroline Tscherpel, Gabriele Stoffels, Ian Law, Otto M. Henriksen, Aida Muhic, Hans S. Poulsen, Jan Steger, Elena K. Bauer, Philipp Lohmann, Matthias Schmidt, Nadim J. Shah, Gereon R. Fink, Karl Josef Langen
Dyk ned i forskningsemnerne om 'Early treatment response evaluation using FET PET compared to MRI in glioblastoma patients at first progression treated with bevacizumab plus lomustine'. Sammen danner de et unikt fingeraftryk.